Alum Binding Proteins
Exclusively Licensed
Invention type: Technology, Tangible Property
/
Case number: #21571H
The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
Researchers
Darrell J Irvine
/
Yash Agarwal
/
Tyson Moyer
/
Karl Dane Wittrup
Departments: David H Koch Institute for Integrative Cancer Res, Department of Chemical Engineering
Technology Areas: Chemicals & Materials: Metals, Nanotechnology & Nanomaterials / Therapeutics: Cell Based Therapy, Proteins & Antibodies
Impact Areas: Healthy Living
-
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
United States of America | Published application -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
United States of America | Granted | 11,642,409 -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
Japan | Published application -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
Japan | Published application -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
European Patent Convention | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.